Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ectopic Lipid Deposition and Insulin Resistance in After Treatment of Acromegaly

NCT01819883 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT01819883
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01819883 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ectopic Lipid Deposition and Insulin Resistance in After Treatment of Acromegaly
Lead sponsor
Massachusetts General Hospital
Phase
Observational
Overall status
Completed
Start date
April 30, 2013
Completion date
March 30, 2016
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acromegaly